Dark

Check out our Dark Pool Levels

BRPA
Big Rock Partners Acquisition Corp. Common Stock
stock NASDAQ

Inactive

May 24, 2021

24.25USD-11.882%(-3.27)287,782

Pre-market

0.00USD-100.000%(-27.52)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

06:52AM EDT NRx Pharmaceuticals, Inc. To Commence Trading On Nasdaq As NRXP, Following Merger Between NeuroRx, Inc. And Big Rock Partners Acquisition Corp Benzinga

06:49AM EDT NRx Pharma Begins Trading On Nasdaq As NRXP, Following Merger Between NeuroRx And Big Rock Partners Acquisition RTTNews

06:48AM EDT NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger PR Newswire

Apr 28, 2021

02:19PM EDT Big Rock Partners Acquisition Merger Partner NeuroRx and Georgian Ministry of Health Agree to Initiate Expanded Access Program of ZYESAMI For COVID-19 Respiratory Failure in Georgia Benzinga

02:13PM EDT Program of ZYESAMI (aviptadil acetate) for COVID-19 Respiratory Failure in Georgia PR Newswire

Apr 26, 2021

09:38AM EDT Dr. Anthony Fauci Confirms ZYESAMI Phase 3 Trial With Remdesivir RTTNews

09:36AM EDT Dr. Anthony Fauci Confirms ZYESAMI Phase 3 Trial with Remdesivir at Press PR Newswire

Apr 19, 2021

03:58PM EDT NeuroRx Responds to Issues Raised by Relief Therapeutics Regarding ZYESAMI PR Newswire

Apr 8, 2021

09:21AM EDT Big Rock Partners Acquisition Corp. Wednesday Urged Stockholders To Vote "For" Extension Amendment Proposal Benzinga

Apr 6, 2021

01:22AM EDT NeuroRx Says Aviptadil Identified By NIH As One Of Two Drugs Selected For Inclusion In Phase III Clinical Trial RTTNews

01:01AM EDT NeuroRx Announces Zyesami(tm) (Aviptadil) Has Been Selected for Inclusion in PR Newswire

Mar 29, 2021

11:02AM EDT What's Going On With BRPA Stock And X Stock Today? Benzinga

07:53AM EDT /C O R R E C T I O N -- NeuroRx/ PR Newswire

01:05AM EDT Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19 PR Newswire

Mar 26, 2021

09:37AM EDT NeuroRx Announces Completion Of Data Analysis In Phase 2b/3 Clinical Trial For ZYESAMI For Treatment Of COVID-19 Respiratory Failure Benzinga

09:36AM EDT NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of PR Newswire

Mar 15, 2021

07:19AM EDT Neurorx, Inc. and Big Rock Partners Acquisition Corp. Announce Committed $10M Pipe to Support Proposed Business Combination Benzinga

Mar 9, 2021

10:20AM EST NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration PR Newswire

Feb 23, 2021

01:13PM EST NeuroRx Announces That ZYESAMI Has Successfully Demonstrated 10-Day Accelerated Recovery From Respiratory Failure In Critically Ill Patients With COVID-19 Treated With High Flow Nasal Oxygen At 28-Day Interim Endpoint Benzinga

01:11PM EST 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint PR Newswire

Feb 19, 2021

06:50PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds GIX, ALXN, STPK, and BRPA Shareholders PR Newswire

Feb 12, 2021

12:17PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, JWS, BRPA and KTYB Shareholders PR Newswire

Feb 9, 2021

12:27PM EST Mid-Day Market Update: KalVista Pharmaceuticals Jumps Following Positive HAE Readout; Ekso Bionics Shares Slide Benzinga

10:23AM EST Mid-Morning Market Update: Markets Mixed; Bitcoin Hits Record High Benzinga

08:14AM EST Benefit of ZYESAMI(tm) (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19 PR Newswire

07:37AM EST NeuroRx, Relief Therapeutics Report Preliminary Results From Phase 2b/3 Trial Of ZYESAMI RTTNews

07:30AM EST Demonstrating Significant Benefit of ZYESAMI(tm) in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19 PR Newswire

Feb 7, 2021

06:53PM EST Lifshitz Law Firm, P.C. Announces Investigation of BRPA, CGRO, GXGX, HEC, FSRV, PR Newswire

Feb 5, 2021

02:34PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, JWS, and BRPA Shareholders About PR Newswire

Jan 29, 2021

05:47PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds JWS, BRPA, and UROV Shareholders About PR Newswire

Jan 22, 2021

03:45PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, JWS, BRPA, and ZAGG Shareholders PR Newswire

Jan 14, 2021

05:19PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, FIII, JWS and BRPA Shareholders PR Newswire

Jan 11, 2021

01:39AM EST NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG (RLFTF) announced Monday that the companies signed a Clinical Trial Participation Agreement with Quantum Leap Healthcare Collaborative or QLHC for the inclusion of ZYESAMI (RLF-100: aviptadil) in the I-SPY COVID-19 Clinical Trial. RTTNews

01:02AM EST NeuroRx And QLHC Sign Clinical Trial Participation Deal For Inclusion Of ZYESAMI In I-SPY COVID-19 Clinical Trial RTTNews

01:00AM EST NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI(tm) PR Newswire

Jan 7, 2021

04:06PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds FIII, JWS, BRPA, and CGIX Shareholders PR Newswire

Dec 30, 2020

09:00PM EST SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Big PR Newswire

01:00AM EST NeuroRx and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100(tm) PR Newswire

Dec 22, 2020

07:11PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, BRPA, and TPGY Shareholders PR Newswire

10:27AM EST Mid-Morning Market Update: Markets Mixed; CarMax Profit Tops Expectations Benzinga

Dec 15, 2020

06:02PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates Big Rock Partners Acquisition Corp. PR Newswire

Dec 14, 2020

10:24AM EST Shares of Big Rock Partners Acquisition Corp. (BRPA) are currently gaining about 7% after the special purpose acquisition company announced merger with NeuroRx Inc. RTTNews

Share